Overview

Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean Subjects

Status:
Completed

Trial end date:
2021-05-10

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to demonstrate the bioequivalence between IN-A012 and Akynzeo capsules by pharmacokinetic(PK) evaluation

Phase:

Phase 1

Details

Lead Sponsor:

HK inno.N Corporation